Effect of collagen peptides on cognitive function

JRCT ID: jRCTs061190029

Registered date:14/01/2020

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Non
• Date of first enrollment: 01/02/2020
• Target sample size: 50
• Study type: Interventional

Intervention(s)

CH group: Collagen peptides 5g / day taken orally for 3 months.
Placebo group: Maltodextrin 5g / day taken orally for 3 months.

Outcome(s)

• Primary Outcome: MCI, HbA1c, blood sugar, blood insulin, AGEs
• Secondary Outcome: Pulse wave velocity, carotid echo, grip strength, sway of gravity, single-leg standing test, general blood collection (anemia, liver function, kidney function, LDL cholesterol, HDL cholesterol, triglyceride, BNP, thyroid function, etc.), bone density measurement, questionnaire

Key inclusion & exclusion criteria

• Age minimum: >= 40age old
• Age maximum: <= 90age old
• Gender: Both

Include criteria

1. Healthy person aged from 40 to 90 years old.
2. HbA1c is 6.0% or less.
3. Intake rate of 80% or more for 3 months.

Exclude criteria

1. Persons with a history of serious illness.
2. Those who have abnormal liver function and renal function test values(Based on the standard values of Ehime University Hospital as of December 1, 2019).
3. Persons who have impaired cardiopulmonary function.
4. Those with food and drug allergies.
5. Those who have undergone gastrointestinal surgery.
6. Persons with chronic or acute infectious diseases at the discretion of doctors.
7. Participants in other clinical trials at the start of this study.
8. Those who play intense sports and are on a diet.
9. Pregnant person.
10. Those who are clearly demented(Exclude 19 points or less on the Hasegawa scale).
11.Those who are already being treated for diabetes
12. Other persons who are judged inappropriate by the investigator.

Related Information

• Primary Sponsor: Igase Michiya
• Source(s) of Monetary Support: Nitta Gelatin Inc.